Literature DB >> 11278492

Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines.

J Charlwood1, C Dingwall, R Matico, I Hussain, K Johanson, S Moore, D J Powell, J M Skehel, S Ratcliffe, B Clarke, J Trill, S Sweitzer, P Camilleri.   

Abstract

Amyloid 39-42 beta -peptides are the main components of amyloid plaques found in the brain of Alzheimer's disease patients. Amyloid 39-42 beta-peptide is formed from amyloid precursor protein by the sequential action of beta- and gamma-secretases. Asp-2 is a transmembrane aspartic protease expressed in the brain, shown to have beta-secretase activity. Mature Asp-2 has four N-glycosylation sites. In this report we have characterized the carbohydrate structures in this glycoprotein expressed in three different cell lines, namely Chinese hamster ovary, CV-1 origin of SV40, and baculovirus-infected SF9 cells. Biantennary and triantennary oligosaccharides of the "complex" type were released from glycoprotein expressed in the mammalian cells, whereas mannose-rich glycans were identified from glycoprotein synthesized in the baculovirus-infected cells. Site-directed mutagenesis of the asparagine residues at amino acid positions 153, 172, 223, and 354 demonstrate that the protease activity of Asp-2 is dependent on its glycosylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278492     DOI: 10.1074/jbc.M009361200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1.

Authors:  Lujia Zhou; Lucia Chávez-Gutiérrez; Katrijn Bockstael; Ragna Sannerud; Wim Annaert; Patrick C May; Eric Karran; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

2.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

Review 3.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 4.  The beta-secretase, BACE: a prime drug target for Alzheimer's disease.

Authors:  R Vassar
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 5.  Splice variants of the Alzheimer's disease beta-secretase, BACE1.

Authors:  R M Damian Holsinger; Nelleke Goense; John Bohorquez; Padraig Strappe
Journal:  Neurogenetics       Date:  2012-11-11       Impact factor: 2.660

6.  Resolving Isomeric Glycopeptide Glycoforms with Hydrophilic Interaction Chromatography (HILIC).

Authors:  Yining Huang; Yongxin Nie; Barry Boyes; Ron Orlando
Journal:  J Biomol Tech       Date:  2016-08-03

7.  Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.

Authors:  Victor P Andreev; Vladislav A Petyuk; Heather M Brewer; Yuliya V Karpievitch; Fang Xie; Jennifer Clarke; David Camp; Richard D Smith; Andrew P Lieberman; Roger L Albin; Zafar Nawaz; Jimmy El Hokayem; Amanda J Myers
Journal:  J Proteome Res       Date:  2012-05-17       Impact factor: 4.466

Review 8.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 9.  Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease.

Authors:  Xiaoman Li; Lin Hong; Kathleen Coughlan; Liang Wang; Liu Cao; Jordan Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-05-15       Impact factor: 3.848

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.